CA
NZ
UK
AU
IND
US
● No clinical readout, regulatory update, financing disclosure or corporate announcement tied to the session could be confirmed.
● Foghorn Therapeutics closed at $2.02 on Friday, October 2, 2026, a decline of 30.82% on the session.
● NoEarningsrelease,Businessupdate, corporate announcement or analyst action could be linked to the session.
● Aldeyra Therapeutics closed at $1.17 on Friday, October 2, 2026, a decline of 9.30% on the session.
● No clinical-trial result, regulatory decision, financing,Partnershipor analyst action could be tied to the session.
● NoEarningsrelease,Businessupdate,Acquisitionor analyst action could be tied to the session.
● BioStem Technologies closed at $2.73 on Friday, October 2, 2026, a decline of 11.07% on the session.
● MSP Recovery's shares began trading on the OTCQB market on December 23, 2025, afterNasdaqmoved to delist the company.
● Panbela moved fromNasdaqto the OTCQB on April 17, 2024, after missing the minimum stockholders'Equityrequirement.
●Nasdaqremoved Virpax in 2025 for missing the minimum stockholders'Equityrequirement, and the company would not appeal.
Please wait processing your request...